Item 8.01. Other Events.

On September 12, 2022, the Company announced the upcoming name and ticker symbol change via a press release. A copy of the press release is filed herewith as Exhibit 99.1 and is incorporated by reference in this Item 8.01.

On September 12, 2022, the Company issued a press release entitled "Invivyd Announces Multiple Next Generation COVID-19 Antibody Candidates and Selects Combination for Clinical Advancement Based on Positive in vitro Data Against Omicron Variants." A copy of the press release is filed herewith as Exhibit 99.2 and is incorporated by reference in this Item 8.01.

On September 12, 2022, the Company posted a corporate presentation on its website at www.Invivyd.com. A copy of the presentation is filed herewith as Exhibit 99.3 and is incorporated by reference in this Item 8.01.

Item 9.01. Financial Statements and Exhibits.




(d) Exhibits

Exhibit
  No.                                       Description

99.1          Press Release, dated September 12, 2022

99.2          Press Release, dated September 12, 2022

99.3          Corporate Presentation, dated September 12, 2022

104         Cover Page Interactive Data File (embedded within the Inline XBRL document)

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses